Jennifer Rosslyn Riggs, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Tyrosine Kinases | 3 | 2021 | 2455 | 0.810 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 3464 | 0.700 |
Why?
|
| Factor VIIa | 4 | 2006 | 101 | 0.660 |
Why?
|
| Pyrimidines | 3 | 2019 | 2943 | 0.590 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 5534 | 0.580 |
Why?
|
| Structure-Activity Relationship | 10 | 2021 | 3130 | 0.520 |
Why?
|
| Pyrroles | 1 | 2019 | 1146 | 0.430 |
Why?
|
| Molecular Structure | 5 | 2021 | 1899 | 0.350 |
Why?
|
| Amidines | 1 | 2006 | 30 | 0.280 |
Why?
|
| Aza Compounds | 1 | 2006 | 32 | 0.280 |
Why?
|
| Carbamates | 1 | 2006 | 196 | 0.240 |
Why?
|
| Prodrugs | 1 | 2006 | 268 | 0.240 |
Why?
|
| Drug Design | 3 | 2019 | 1076 | 0.220 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 13693 | 0.200 |
Why?
|
| Indoles | 2 | 2006 | 1839 | 0.190 |
Why?
|
| Pyrazines | 2 | 2015 | 1230 | 0.170 |
Why?
|
| Models, Molecular | 3 | 2021 | 5451 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1213 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2110 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 16690 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1085 | 0.120 |
Why?
|
| Mice, SCID | 1 | 2019 | 2716 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3554 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2017 | 908 | 0.110 |
Why?
|
| Mitosis | 1 | 2017 | 1208 | 0.100 |
Why?
|
| Rats | 5 | 2019 | 24252 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2011 | 281 | 0.090 |
Why?
|
| Triazoles | 1 | 2015 | 908 | 0.090 |
Why?
|
| Biological Availability | 2 | 2006 | 397 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2019 | 8436 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2015 | 1058 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2011 | 2012 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8432 | 0.060 |
Why?
|
| Animals | 7 | 2019 | 168768 | 0.050 |
Why?
|
| Apoptosis | 1 | 2019 | 9724 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2006 | 3914 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2011 | 2043 | 0.050 |
Why?
|
| Female | 4 | 2021 | 380193 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 23404 | 0.030 |
Why?
|
| Pyridines | 1 | 2006 | 2825 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20824 | 0.030 |
Why?
|
| Mice | 2 | 2018 | 81201 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 11126 | 0.030 |
Why?
|
| Thrombosis | 1 | 2006 | 2968 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2011 | 42 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2006 | 4600 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 459 | 0.020 |
Why?
|
| Humans | 6 | 2021 | 744366 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 626 | 0.020 |
Why?
|
| Urea | 1 | 2011 | 450 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 4010 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 6313 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1730 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1525 | 0.010 |
Why?
|
| Thrombin | 1 | 2006 | 598 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10483 | 0.010 |
Why?
|
| Male | 2 | 2015 | 350115 | 0.010 |
Why?
|